|
Volumn 304, Issue 5678, 2004, Pages 1726-1727
|
Accidental anthrax shipment spurs debate over safety
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRAX VACCINE;
CIPROFLOXACIN;
ACCIDENT;
ANTHRAX;
BACILLUS ANTHRACIS;
BACTERIAL SPORE;
BIOLOGICAL WARFARE;
EBOLA VIRUS;
EXPOSURE;
HEALTH HAZARD;
HUMAN;
INFECTION RISK;
LABORATORY INFECTION;
MEDICAL RESEARCH;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SAFETY;
SARS CORONAVIRUS;
ANIMAL;
ARTICLE;
HAZARDOUS WASTE;
MOUSE;
UNITED STATES;
ANTHRAX;
BACILLUS ANTHRACIS;
BACTERIA (MICROORGANISMS);
CORONAVIRUS;
EBOLA VIRUS;
SARS CORONAVIRUS;
ANIMALS;
ANTHRAX;
ANTHRAX VACCINES;
BACILLUS ANTHRACIS;
CONTAINMENT OF BIOHAZARDS;
HUMANS;
LABORATORY INFECTION;
MICE;
SAFETY MANAGEMENT;
UNITED STATES;
|
EID: 3142626728
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (4)
|
References (0)
|